Who We Are
ETERN is an Innovative Precision Oncology Company Focusing on Developing Novel Small Molecule Drugs to Inhibit “Undruggable” Targets, a Cutting-Edge and Highly Sought-After Area in Pharmaceutical Industry
“Undruggable” Targets
Science
- Many Key Cancer Targets are "Undruggable" by the Existing Technology
- We Develop Novel Technology for Targeting "Undruggable" Targets